A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

Super Agers author Eric Topol unpacks the rise of biological age tests—from organ clocks to immune system clocks—and how they might revolutionize early diagnosis of disease ...

For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...

HXN-1001 is a half-life extended next-generation anti-TL1A antibody with great potential for the treatment of patients with inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's ...

Amgen Inc. (NASDAQ: AMGN) is one of the. On June 23, the company announced full results from Part 1 of the Phase 2 study of ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

Sarilumab treatment with a rapid glucocorticoid taper in relapsing polymyalgia rheumatica shows greater improvements in ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...